Treatment MarketThe global urinary tract infection (UTI) treatment market is poised for consistent growth, with an estimated ...

You can not sell your investments in this fund for 3 years from the purchase date. Long term capital gain tax will be applicable when you sell your investments after 3 years. Current tax rate is ...

Oct 25 (Reuters) - The U.S. Food and Drug Administration has approved Iterum Therapeutics' (ITRM.O), opens new tab oral antibiotic to treat certain types of bacterial urinary tract infections (UTI ...

Sulopenem, which will now go by the commercial moniker Orlynvah, was approved by the FDA Friday to treat uncomplicated urinary tract infections (uUTIs) caused by E. coli, Klebsiella pneumoniae or ...

for the treatment of uncomplicated urinary tract infections (uUTIs) caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women who have ...

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades --Company to Host Conference Call on Monday, October 28 th ...

Complicated urinary tract infections (cUTI) or as step-down treatment after intravenous antibacterial treatment of cUTI. Complicated intra-abdominal infections (cIAI) or as step-down treatment ...

A urinary tract infection (UTI) happens when bacteria enter your urethra and bladder. Most people need antibiotics to treat a UTI, and these medications can clear up a UTI within 24-48 hours in most ...

for the treatment of uncomplicated urinary tract infections (uUTIs) caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women who have ...

When a huge tract of land on the Somerset coast was deliberately flooded, the project was slammed as “ridiculous” by a local lawmaker. But the results have been transformative. When a huge ...